Scholar Rock Holding Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Scholar Rock Holding Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report1 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+9.96%
vs ±11.7% implied · ×0.85
shaded = implied · ▲▼ = realized
Scholar Rock has 3 disclosed suppliers and 2 disclosed customers in SEC filings.
Scholar Rock Holding Corp
43.90
SentenceUnder the Adimab Agreement, as amended, we selected a number of biological targets against which Adimab used its proprietary platform technology to discover and/or optimize antibodies based upon mutually agreed upon research plans, and we have the ability to select a specified number of additional biological targets against which Adimab will provide additional antibody discovery and optimization services.
SRRK 10-Kaccession 0001104659-26-022551
SentenceConcurrently with the entry into the Financing Agreement, we also entered into a Pledge and Security Agreement (the "Security Agreement", together with the Financing Agreement, the "2026 Loan Agreement") with Blue Owl.
SRRK 10-Kaccession 0001104659-26-022551
SentenceOn November 14, 2022, we entered into a sales agreement with Jefferies LLC ("Jefferies"), pursuant to which we may offer and sell our common stock, subject to certain limitations in the sales agreement and compliance with applicable law, at any time throughout the term of the sales agreement.
SRRK 10-Kaccession 0001104659-26-022551
PCT/US2017/042162 (published as WO 2018/013939) was exclusively licensed to Janssen but, as explained below, the license agreement was terminated in July 2022.
SRRK 10-Kaccession 0001104659-26-022551
Linked news
NewsExpected move
Inputs8Q avg ±6.6%·×0.21·cheap
straddle ±9.5%
spot 43.90exp Nov 20ATM strike 45ATM straddle 4.90IV 57%